(MYMD) |
|
0 (0%)
|
09-28 21:20 |
|
Open: |
|
Pre. Close: |
|
|
High:
|
|
Low:
|
|
|
Volume:
|
0 |
Market Cap:
|
0(M) |
|
|
|
Technical analysis |
as of: 2023-09-28 4:52:10 PM |
|
Short-term rate:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 1.03  One year: 1.34 |
| Support: |
Support1: 0.44 Support2: 0.37 |
| Resistance: |
Resistance1: 0.88 Resistance2: 1.14 |
| Pivot: |
0.59 |
| Moving Average: |
MA(5): 0.52 MA(20): 0.66
MA(100): 1.31 MA(250): 1.68 |
| MACD: |
MACD(12,26): -0.2  Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 19.5 %D(3): 16.1 |
| RSI: |
RSI(14): 33.4 |
| 52-week: |
High: 3.29 Low: 0.44 |
| Average Vol(K): |
3-Month: 824 (K) 10-Days: 716 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MYMD ] has closed above bottom band by 36.0%. Bollinger Bands are 46.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.55 - 0.55 |
0.55 - 0.56 |
|
Low:
|
0.51 - 0.51 |
0.51 - 0.51 |
|
Close:
|
0.54 - 0.55 |
0.55 - 0.55 |
|
Company Description |
|
|
Headline News |
Mon, 25 Sep 2023
15.0% of DIV Holdings Seeing Recent Insider Buys - Nasdaq
Mon, 25 Sep 2023
Sarcopenia Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated) - Benzinga
Thu, 21 Sep 2023
Sarcopenia Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA - Benzinga
Mon, 11 Sep 2023
MyMD-1 by MyMD Pharmaceuticals for Type 2 Diabetes: Likelihood ... - Pharmaceutical Technology
Thu, 17 Aug 2023
FDA approves MyMD's Phase II rheumatoid arthritis trial - Clinical Trials Arena
Wed, 02 Aug 2023
MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: |
| Sector: |
| Industry: |
| Shares Out. |
45 (M) |
| Shares Float |
38 (M) |
|
% Held by Insiders
|
17.2 (%) |
|
% Held by Institutions
|
10.7 (%) |
|
Shares Short
|
2,950 (K) |
|
Shares Short P.Month
|
4,030 (K) |
Stock Financials |
|
EPS
|
-0.42 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.25 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-42.6 |
|
Return on Equity (ttm)
|
-95 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-14 (M) |
|
Levered Free Cash Flow
|
-8 (M) |
Stock Valuations |
|
PE Ratio
|
-1.31 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.18 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-1.73 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
